Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
02/2001
02/08/2001WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof
02/08/2001WO2000063426A3 Compound screening methods
02/08/2001WO2000063424A3 Method for screening compounds using nematode worms
02/08/2001CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
02/08/2001CA2380813A1 Human monoclonal antibodies to her2/neu
02/08/2001CA2379819A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
02/08/2001CA2379360A1 Human g-protein coupled receptor
02/07/2001EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
02/07/2001EP1073765A2 Gene screening methods and related assays
02/07/2001EP1073745A2 Immunization against and treatment for infection by h. pylori
02/07/2001EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
02/07/2001CN2417701Y Thread-ribbed cardboard grid pile
02/07/2001CN2417700Y Frame-type scorpion-raising apparatus
02/07/2001CN1283233A Variant loxP sequences and application of the same
02/07/2001CN1283230A Desaturated enzyme
02/07/2001CN1282512A Technique for culturing Fuxing crucian carp
02/06/2001US6184436 Transgenic mice expressing HIV-1 in immune cells
02/06/2001US6184351 Artificial brain protein; for the treatment of alzheimer's and parkinson's disease
02/06/2001US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof
02/06/2001US6183740 Recombinant bacterial phytases and uses thereof
02/01/2001WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same
02/01/2001WO2001007021A2 Process for the improvement of spermatozoa fertilization activity
02/01/2001WO2001006849A1 Transgenic animal model for kaposi's sarcoma
02/01/2001WO2001006848A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases
02/01/2001WO2000060095A3 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
02/01/2001WO2000043781A3 Growth differentiation factor inhibitors and uses therefor
02/01/2001WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/01/2001CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same
02/01/2001CA2378650A1 Process for the improvement of spermatozoa fertilization activity
01/2001
01/31/2001EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use
01/31/2001EP1072189A1 Device for breeding snails
01/31/2001EP1071823A2 Novel mutations in the (freac3 )gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
01/31/2001EP1071822A2 Fetal testing for prediction of low birth weight
01/31/2001EP1071796A1 Regulable gene expression in gram-positive bacteria
01/31/2001EP1071788A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
01/31/2001EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
01/31/2001EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
01/31/2001EP1071762A1 Control of gene expression
01/31/2001EP1071756A1 PURIFICATION OF HUMAN ACID $g(a)-GLUCOSIDASE
01/31/2001EP1071755A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
01/31/2001EP1071751A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa
01/31/2001EP1071710A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
01/31/2001EP1071471A2 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
01/31/2001CN1282372A Mammalian sytokine-like polypeptide-10
01/31/2001CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof
01/30/2001US6180761 Casein from Korean cattle
01/30/2001US6178921 Method of improving breeding conditions in newborn pigs
01/30/2001CA2313825A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use
01/25/2001WO2001006262A1 Diagnostics and therapeutics for macular degeneration
01/25/2001WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6
01/25/2001WO2001005955A2 Animals comprising human hepatocellular tissue
01/25/2001WO2001005222A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
01/25/2001WO2000068399A3 Vector-mediated delivery of integrating transposon sequences
01/25/2001WO2000060080A3 Molecules of the immune system
01/25/2001WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
01/25/2001WO2000054815A3 Expression of dna or proteins in c. elegans
01/25/2001WO2000054580A3 Leukotriene b4 receptor transgenic mammals
01/25/2001DE10034165A1 Electrically operated snail clearance device for garden
01/25/2001CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6
01/25/2001CA2375943A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
01/24/2001EP1070454A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor
01/24/2001EP1070134A2 Growth differentiation factor-9 regulatory sequences and uses therefor
01/24/2001EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules
01/24/2001EP1070030A1 Treatment of waste materials
01/24/2001CN2415603Y Domestic scorpion rearing equipment
01/24/2001CN1281337A Drinking water additive for birds and method of administering same
01/24/2001CN1060915C Pesticide composition for fruit tree putrefaction disease
01/23/2001US6177242 Genomic DNA fragments containing regulatory and coding sequences for the β2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
01/23/2001US6176199 Method for localizing allantoic fluid of avian eggs
01/18/2001WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy
01/18/2001WO2001004318A2 Myxoma virus genes for immune modulation
01/18/2001WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON)
01/18/2001CA2378982A1 Methods of inhibiting muscle atrophy
01/18/2001CA2378567A1 Novel myxoma genes for immune modulation
01/17/2001EP1068799A2 Biological models capable of exhibiting secondary disease manifestations
01/17/2001EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice
01/17/2001EP1068315A2 Therapeutic agent for ngf
01/17/2001EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof
01/17/2001EP1067968A1 Methods for evaluating a compound for its effect on skin
01/17/2001EP1067834A1 Porcine nuclear transfer
01/17/2001CN2414619Y Automatic machine for making straw rope net for cocooning
01/17/2001CN1280618A Protein involved in abscisic acid signalling
01/16/2001US6175057 Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
01/16/2001US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning
01/16/2001CA2093659C Dna sequence encoding bovine .alpha.-lactalbumin and methods of use
01/11/2001WO2001002866A1 Diagnostics and therapeutics for arterial wall disruptive disorders
01/11/2001WO2001002593A2 Control of gene expression in eukaryotic cells
01/11/2001WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
01/11/2001WO2001002557A1 Neurotrophic factor receptor
01/11/2001WO2001002552A2 Double transgenic animals as models for neurodegenerative disease
01/11/2001WO2001002550A2 Cell death related drug targets in yeast and fungi
01/11/2001WO2001002019A2 Control of gene expression
01/11/2001WO2001001767A1 Hydrocephaly model animals
01/11/2001WO2000053738A3 Methods and compositions for regulating memory consolidation
01/11/2001WO2000046251A3 Human polyclonal antibodies from transgenic nonhuman animals
01/11/2001WO2000032226B1 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof
01/11/2001DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the
01/11/2001CA2380875A1 Cell death related drug targets in yeast and fungi
01/11/2001CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
01/11/2001CA2377932A1 Control of gene expression in eukaryotic cells